GB0203830D0 - Improving drug delivery to the respiratory tract - Google Patents

Improving drug delivery to the respiratory tract

Info

Publication number
GB0203830D0
GB0203830D0 GB0203830A GB0203830A GB0203830D0 GB 0203830 D0 GB0203830 D0 GB 0203830D0 GB 0203830 A GB0203830 A GB 0203830A GB 0203830 A GB0203830 A GB 0203830A GB 0203830 D0 GB0203830 D0 GB 0203830D0
Authority
GB
United Kingdom
Prior art keywords
drug delivery
respiratory tract
improving drug
improving
respiratory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB0203830A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Southampton
Original Assignee
University of Southampton
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Southampton filed Critical University of Southampton
Priority to GB0203830A priority Critical patent/GB0203830D0/en
Publication of GB0203830D0 publication Critical patent/GB0203830D0/en
Priority to DK03702776.0T priority patent/DK1513502T3/en
Priority to CA2516331A priority patent/CA2516331C/en
Priority to PT37395779T priority patent/PT1549337E/en
Priority to AU2003245794A priority patent/AU2003245794A1/en
Priority to CA2516318A priority patent/CA2516318C/en
Priority to PCT/GB2003/000663 priority patent/WO2003068187A1/en
Priority to ES03702776.0T priority patent/ES2565028T3/en
Priority to AT03704789T priority patent/ATE410147T1/en
Priority to PCT/GB2003/000703 priority patent/WO2003068188A1/en
Priority to AU2003207317A priority patent/AU2003207317A1/en
Priority to EP03702776.0A priority patent/EP1513502B1/en
Priority to EP03704789.1A priority patent/EP1511466B2/en
Priority to ES03739577.9T priority patent/ES2527096T3/en
Priority to DK03704789.1T priority patent/DK1511466T4/en
Priority to PCT/GB2003/000668 priority patent/WO2003068254A1/en
Priority to PT03704789T priority patent/PT1511466E/en
Priority to CA2516322A priority patent/CA2516322C/en
Priority to ES03704789.1T priority patent/ES2315479T5/en
Priority to DE60323973T priority patent/DE60323973D1/en
Priority to EP03739577.9A priority patent/EP1549337B1/en
Priority to AU2003205898A priority patent/AU2003205898A1/en
Priority to DK03739577.9T priority patent/DK1549337T3/en
Priority to HK05107959.9A priority patent/HK1074582A1/en
Pending legal-status Critical Current

Links

GB0203830A 2002-02-18 2002-02-18 Improving drug delivery to the respiratory tract Pending GB0203830D0 (en)

Priority Applications (24)

Application Number Priority Date Filing Date Title
GB0203830A GB0203830D0 (en) 2002-02-18 2002-02-18 Improving drug delivery to the respiratory tract
DK03739577.9T DK1549337T3 (en) 2002-02-18 2003-02-14 COMBINATION OF DNASE I AND GLYCOSAMINOGLYCANES FOR USE IN EXTRACELLULAR DNA CLEARANCE
AU2003207317A AU2003207317A1 (en) 2002-02-18 2003-02-14 Use of glycosaminoglycans such as e.g. heparin for the treatment of respiratory disorders such as copd
EP03704789.1A EP1511466B2 (en) 2002-02-18 2003-02-14 Use of glycosaminoglycans such as e.g. heparin for the treatment of respiratory disorders such as copd
PT37395779T PT1549337E (en) 2002-02-18 2003-02-14 Combination of dnase i and glycosaminoglycans for use in extracellular dna clearance
AU2003245794A AU2003245794A1 (en) 2002-02-18 2003-02-14 Glycosaminoglycan-dnase combination therapy
CA2516318A CA2516318C (en) 2002-02-18 2003-02-14 Use of glycosaminoglycans such as heparin for the treatment of respiratory disorders such as copd
PCT/GB2003/000663 WO2003068187A1 (en) 2002-02-18 2003-02-14 Use of glycosaminoglycans such as e.g. heparin for the treatment of respiratory disorders such as copd
ES03702776.0T ES2565028T3 (en) 2002-02-18 2003-02-14 Combination therapy for respiratory disorders
AT03704789T ATE410147T1 (en) 2002-02-18 2003-02-14 USE OF GLYCOSAMIN GLYCANS SUCH AS HEPARIN TO TREAT RESPIRATORY DISEASES SUCH AS COPD
PCT/GB2003/000703 WO2003068188A1 (en) 2002-02-18 2003-02-14 Combination therapy for respiratory disorders
DK03702776.0T DK1513502T3 (en) 2002-02-18 2003-02-14 Combination therapy for airway disorders
EP03702776.0A EP1513502B1 (en) 2002-02-18 2003-02-14 Combination therapy for respiratory disorders
CA2516331A CA2516331C (en) 2002-02-18 2003-02-14 Combination therapy using glycosaminoglycans and therapeutic agents for the treatment of respiratory disorders
ES03739577.9T ES2527096T3 (en) 2002-02-18 2003-02-14 Combination of DNase I and glycosaminoglycans for use in cleaning extracellular DNA
DK03704789.1T DK1511466T4 (en) 2002-02-18 2003-02-14 Use of glycosaminoglycans, such as, for example, heparin, for the treatment of respiratory disorders such as COPD
PCT/GB2003/000668 WO2003068254A1 (en) 2002-02-18 2003-02-14 Glycosaminoglycan-dnase combination therapy
PT03704789T PT1511466E (en) 2002-02-18 2003-02-14 Use of glycosaminoglycans such as e.g. heparin for the treatment of respiratory disorders such as copd
CA2516322A CA2516322C (en) 2002-02-18 2003-02-14 Glycosaminoglycan-dnase combination therapy
ES03704789.1T ES2315479T5 (en) 2002-02-18 2003-02-14 Use of glycosaminoglycans such as eg Heparin for the treatment of respiratory disorders such as COPD
DE60323973T DE60323973D1 (en) 2002-02-18 2003-02-14 USE OF GLYCOSAMINO LYCANES SUCH AS FOR EXAMPLE. HEPARIN FOR THE TREATMENT OF RESPIRATORY DISEASES SUCH AS COPD
EP03739577.9A EP1549337B1 (en) 2002-02-18 2003-02-14 Combination of DNase I and glycosaminoglycans for use in extracellular DNA clearance
AU2003205898A AU2003205898A1 (en) 2002-02-18 2003-02-14 Combination therapy for respiratory disorders
HK05107959.9A HK1074582A1 (en) 2002-02-18 2005-09-09 Use of glycosaminoglycans such as e.g. heparin for the treatment of respiratory disorders such as copd

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0203830A GB0203830D0 (en) 2002-02-18 2002-02-18 Improving drug delivery to the respiratory tract

Publications (1)

Publication Number Publication Date
GB0203830D0 true GB0203830D0 (en) 2002-04-03

Family

ID=9931309

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0203830A Pending GB0203830D0 (en) 2002-02-18 2002-02-18 Improving drug delivery to the respiratory tract

Country Status (1)

Country Link
GB (1) GB0203830D0 (en)

Similar Documents

Publication Publication Date Title
IL174690A0 (en) Enhanced drug delivery
EP1755717A4 (en) Nasal cannula
HK1128250A1 (en) Aerosol medication inhalation system
EP1750677A4 (en) Oral therapeutic compound delivery system
AU154760S (en) Inhaler
IL174396A0 (en) Oral drug delivery system
IL157580A0 (en) Inhalation drug combination
GB2400565B (en) Nasal drug delivery
HK1080015A1 (en) Drug delivery assembly
GB0304636D0 (en) Pharmaceutical composition for nasal delivery
GB0228305D0 (en) Therapeutic composition for respiratory delivery
GB0308771D0 (en) Pulmonary drug delivery
AUPS286302A0 (en) Medication inhaler
GB0203830D0 (en) Improving drug delivery to the respiratory tract
GB0203773D0 (en) Improving drug delivery to the respiratory tract
AU153471S (en) Inhaler
AU153470S (en) Inhaler
PL1653963T3 (en) Nasal pharmaceutical piribedil composition
AU2003229137A8 (en) Medication inhaler
GB0210020D0 (en) Medical agent delivery
GB0329041D0 (en) Nasal drug delivery
GB0319823D0 (en) Breath-actuated inhaler
GB0518063D0 (en) Improvements in the nasal administration of medicaments
GB0206856D0 (en) Improved medical inhaler
TW592137U (en) Nasal inhaler